303 related articles for article (PubMed ID: 18593953)
1. Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver.
Jiang W; Zhu Z; Thompson HJ
Cancer Res; 2008 Jul; 68(13):5492-9. PubMed ID: 18593953
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the activities of AMP-activated protein kinase, protein kinase B, and mammalian target of rapamycin by limiting energy availability with 2-deoxyglucose.
Jiang W; Zhu Z; Thompson HJ
Mol Carcinog; 2008 Aug; 47(8):616-28. PubMed ID: 18247380
[TBL] [Abstract][Full Text] [Related]
3. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
Kimball SR; Siegfried BA; Jefferson LS
J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
[TBL] [Abstract][Full Text] [Related]
4. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
Thomson DM; Fick CA; Gordon SE
J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
[TBL] [Abstract][Full Text] [Related]
5. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
Han S; Khuri FR; Roman J
Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
[TBL] [Abstract][Full Text] [Related]
7. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
Bishop JD; Nien WL; Dauphinee SM; Too CK
J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro.
Zhu Z; Jiang W; McGinley JN; Thompson HJ
Cancer Res; 2005 Aug; 65(15):7023-30. PubMed ID: 16061689
[TBL] [Abstract][Full Text] [Related]
9. Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling.
Deshmukh AS; Treebak JT; Long YC; Viollet B; Wojtaszewski JF; Zierath JR
Mol Endocrinol; 2008 May; 22(5):1105-12. PubMed ID: 18276828
[TBL] [Abstract][Full Text] [Related]
10. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
11. Administration of triiodo-L-thyronine into dorsal hippocampus alters phosphorylation of Akt, mammalian target of rapamycin, p70S6 kinase and 4E-BP1 in rats.
Sui L; Wang J; Li BM
Neurochem Res; 2008 Jun; 33(6):1065-76. PubMed ID: 18097751
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
Lang CH; Frost RA
J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression and phosphorylation of 4E-BP1, a main target of mTOR signaling, in rat mammary carcinomas: an association with etiology.
Takabatake M; Daino K; Imaoka T; Nishimura M; Morioka T; Fukushi M; Shimada Y
In Vivo; 2011; 25(6):853-60. PubMed ID: 22021677
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ
J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
J Biol Chem; 2002 Jul; 277(27):23977-80. PubMed ID: 11997383
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells.
Lee HJ; Mariappan MM; Feliers D; Cavaglieri RC; Sataranatarajan K; Abboud HE; Choudhury GG; Kasinath BS
J Biol Chem; 2012 Feb; 287(7):4451-61. PubMed ID: 22158625
[TBL] [Abstract][Full Text] [Related]
17. Medium-chain triacylglycerol suppresses the decrease of plasma albumin level through the insulin-Akt-mTOR pathway in the livers of malnourished rats.
Sekine S; Terada S; Aoyama T
J Nutr Sci Vitaminol (Tokyo); 2013; 59(2):123-8. PubMed ID: 23727642
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle.
Saha AK; Xu XJ; Lawson E; Deoliveira R; Brandon AE; Kraegen EW; Ruderman NB
Diabetes; 2010 Oct; 59(10):2426-34. PubMed ID: 20682696
[TBL] [Abstract][Full Text] [Related]
19. Determinants of rapamycin sensitivity in breast cancer cells.
Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F
Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980
[TBL] [Abstract][Full Text] [Related]
20. Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
Din FV; Valanciute A; Houde VP; Zibrova D; Green KA; Sakamoto K; Alessi DR; Dunlop MG
Gastroenterology; 2012 Jun; 142(7):1504-15.e3. PubMed ID: 22406476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]